Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China.

MLA

Huang, Rui, et al. “Gamma-Glutamyl-Transpeptidase to Platelet Ratio Is Not Superior to APRI,FIB-4 and RPR for Diagnosing Liver Fibrosis in CHB Patients in China.” Scientific Reports, vol. 7, no. 1, Aug. 2017, p. 8543. EBSCOhost, https://doi.org/10.1038/s41598-017-09234-w.

APA

Huang, R., Wang, G., Tian, C., Liu, Y., Jia, B., Wang, J., Yang, Y., Li, Y., Sun, Z., Yan, X., Xia, J., Xiong, Y., Song, P., Zhang, Z., Ding, W., & Wu, C. (2017). Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China. Scientific Reports, 7(1), 8543. https://doi.org/10.1038/s41598-017-09234-w

Chicago

Huang, Rui, Guiyang Wang, Chen Tian, Yong Liu, Bei Jia, Jian Wang, Yue Yang, et al. 2017. “Gamma-Glutamyl-Transpeptidase to Platelet Ratio Is Not Superior to APRI,FIB-4 and RPR for Diagnosing Liver Fibrosis in CHB Patients in China.” Scientific Reports 7 (1): 8543. doi:10.1038/s41598-017-09234-w.